Key Laboratory for Traditional Chinese Korean Medicine of Jilin Province, College of Pharmacy, Yanbian University, Yanji, China.
Clinical Research Center, Yanbian University Hospital, Yanji, China.
Br J Pharmacol. 2020 Jun;177(12):2793-2811. doi: 10.1111/bph.15007. Epub 2020 Feb 23.
Regulating macrophage-hepatocyte crosstalk through P2X7 receptors has led to new pharmacological strategies to reverse alcoholic hepatosteatosis. We investigated how tetrahydroxystilbene glucoside (2354glu), isolated from Polygonum multiflorum, modulates macrophage-hepatocyte crosstalk during alcoholic hepatosteatosis.
A model of alcoholic hepatosteatosis was established by giving ethanol intragastrically to C57BL/6 mice. HepG2 cells were incubated in conditioned medium from LPS+ATP-activated THP-1 human macrophages with silenced or overexpressed P2X7 receptors. THP-1 macrophages or mouse peritoneal macrophages were pretreated with 2354glu for 1 hr prior to LPS+ATP stimulation. Western blots, RT-PCR and immunohistochemical analysis were used, along with over-expression and silencing of P2X7 receptors.
Knockdown or overexpression of P2X7 receptors in THP-1 macrophages affected release of mature IL-1β and, subsequently, modulated lipid metabolism in HepG2 cells via the LKB-AMPK pathway. 2354glu ameliorated alcoholic hepatosteatosis in mice by regulating LKB1-AMPK-SREBP1 pathway and its target genes. Suppression of P2X7 receptor activation by 2354glu inhibited IL-1β release and reduced macrophage and neutrophil infiltration. In macrophages stimulated with LPS+ATP, expression of P2X7 receptors, caspase-1 and NF-κB, release of IL-1β, calcium influx and PI uptake were reduced by 2354glu. SIRT1-LKB1-AMPK-SREBP1 axis-mediated lipid accumulation in HepG2 cells was reduced when they were cultured with conditioned media from LPS+ATP-activated THP-1 macrophages pretreated with 2354glu.
Modulation of P2X7 receptors in macrophages regulated lipid accumulation in hepatocytes during alcoholic hepatosteatosis. 2354glu might be a promising candidate that targets P2X7 receptors in macrophages interacting with hepatocytes during alcoholic hepatosteatosis.
通过 P2X7 受体调节巨噬细胞-肝细胞的相互作用,为逆转酒精性肝脂肪变性提供了新的药物治疗策略。我们研究了从何首乌中分离得到的二苯乙烯苷(2354glu)如何在酒精性肝脂肪变性过程中调节巨噬细胞-肝细胞的相互作用。
通过给 C57BL/6 小鼠灌胃乙醇建立酒精性肝脂肪变性模型。将 HepG2 细胞孵育在 LPS+ATP 激活的沉默或过表达 P2X7 受体的 THP-1 人巨噬细胞的条件培养基中。THP-1 巨噬细胞或小鼠腹腔巨噬细胞在 LPS+ATP 刺激前用 2354glu 预处理 1 小时。采用 Western blot、RT-PCR 和免疫组织化学分析,以及 P2X7 受体的过表达和沉默。
THP-1 巨噬细胞中 P2X7 受体的敲低或过表达影响成熟的 IL-1β的释放,并通过 LKB1-AMPK-SREBP1 途径调节 HepG2 细胞中的脂质代谢。2354glu 通过调节 LKB1-AMPK-SREBP1 途径及其靶基因,改善了小鼠的酒精性肝脂肪变性。2354glu 通过抑制 P2X7 受体的激活,抑制了 IL-1β的释放,减少了巨噬细胞和中性粒细胞的浸润。在 LPS+ATP 刺激的巨噬细胞中,2354glu 降低了 P2X7 受体、半胱天冬酶-1 和 NF-κB 的表达、IL-1β的释放、钙内流和 PI 摄取。当用 LPS+ATP 激活的 THP-1 巨噬细胞预处理的条件培养基培养 HepG2 细胞时,SIRT1-LKB1-AMPK-SREBP1 轴介导的脂质积累减少。
巨噬细胞中 P2X7 受体的调节调节了酒精性肝脂肪变性过程中肝细胞的脂质积累。2354glu 可能是一种有前途的候选药物,它可以靶向酒精性肝脂肪变性过程中与肝细胞相互作用的巨噬细胞中的 P2X7 受体。